| Filed On | Filing |
|---|---|
| 15 Oct 2026 |
8-K: Other Events
As previously disclosed, on April 15, 2026, Mustang Bio, Inc. (the “Company”) received a notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the bid price o... |
| 05 Aug 2026 | 10-Q |
| 05 May 2026 | 10-Q |
| 27 Apr 2026 |
Form 4: Litchman Manuel Md, Director
Gave up 19 shares to cover exercise price or tax ($14.3) |
| 17 Apr 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 19 Mar 2026 | 10-K |
| 05 Jan 2026 |
Form 4: Fortress Biotech, Inc., 10% owner
Received 278,385 shares as a grant or award |
| 05 Jan 2026 | SCHEDULE 13D/A |
| 30 Dec 2025 |
Form 4: Herskowitz Neil, Director
Sold 247 shares ($238) |
| 30 Dec 2025 |
Form 4: Chill Adam J., Director
Sold 4 shares ($3.82) |
| 30 Dec 2025 |
Form 4: Jin David, Director
Bought 247 shares ($238) |
| 23 Dec 2025 | 8-K: Submission of Matters to a Vote of Security Holders; Other Events |
| 03 Dec 2025 |
Proxy statement: annual meeting on December 22, 2025
CEO pay $498K, down 3.2% |
| 07 Nov 2025 | 10-Q |
| 01 Oct 2025 | SCHEDULE 13D/A |
| 01 Oct 2025 |
Form 4: Fortress Biotech, Inc., 10% owner
Received 59,334 shares as a grant or award |
| 05 Sep 2025 | 424B5 |
| 12 Aug 2025 | SCHEDULE 13G/A |
| 08 Aug 2025 | 10-Q |
| 09 Jul 2025 | 8-K: Other Events |
Loading...
